The Laparotomy Study

PHASE4CompletedINTERVENTIONAL
Enrollment

128

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

June 30, 2016

Conditions
Gastrointestinal Cancer
Interventions
DRUG

Group STANDARD: Rocuronium 0.6 mg/kg followed by bolus rocuronium according to standard treatment combined with saline infusion (placebo).

DRUG

Group DEEP: Rocuronium 0.6 mg/kg followed by rocuronium infusion with target level PTC 0-1 combined with bolus saline (placebo) mimicking standard treatment.

Trial Locations (1)

8000

Aarhus University Hospital Nørrebrogade, Aarhus

All Listed Sponsors
lead

Herlev Hospital

OTHER

NCT02140593 - The Laparotomy Study | Biotech Hunter | Biotech Hunter